Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection
- PMID: 37153606
- PMCID: PMC10158532
- DOI: 10.3389/fimmu.2023.1156758
Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection
Abstract
Correlates of protection (CoP) are biological parameters that predict a certain level of protection against an infectious disease. Well-established correlates of protection facilitate the development and licensing of vaccines by assessing protective efficacy without the need to expose clinical trial participants to the infectious agent against which the vaccine aims to protect. Despite the fact that viruses have many features in common, correlates of protection can vary considerably amongst the same virus family and even amongst a same virus depending on the infection phase that is under consideration. Moreover, the complex interplay between the various immune cell populations that interact during infection and the high degree of genetic variation of certain pathogens, renders the identification of immune correlates of protection difficult. Some emerging and re-emerging viruses of high consequence for public health such as SARS-CoV-2, Nipah virus (NiV) and Ebola virus (EBOV) are especially challenging with regards to the identification of CoP since these pathogens have been shown to dysregulate the immune response during infection. Whereas, virus neutralising antibodies and polyfunctional T-cell responses have been shown to correlate with certain levels of protection against SARS-CoV-2, EBOV and NiV, other effector mechanisms of immunity play important roles in shaping the immune response against these pathogens, which in turn might serve as alternative correlates of protection. This review describes the different components of the adaptive and innate immune system that are activated during SARS-CoV-2, EBOV and NiV infections and that may contribute to protection and virus clearance. Overall, we highlight the immune signatures that are associated with protection against these pathogens in humans and could be used as CoP.
Keywords: Ebola virus; Nipah virus; SARS-CoV-2; cell-mediated immunity; emerging viruses; humoral immunity; immune correlates of protection.
Copyright © 2023 Escudero-Pérez, Lawrence and Castillo-Olivares.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells.J Virol. 2019 Jan 17;93(3):e01821-18. doi: 10.1128/JVI.01821-18. Print 2019 Feb 1. J Virol. 2019. PMID: 30429347 Free PMC article.
-
Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease.Front Immunol. 2023 Sep 4;14:1216225. doi: 10.3389/fimmu.2023.1216225. eCollection 2023. Front Immunol. 2023. PMID: 37731485 Free PMC article.
-
Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection.mBio. 2019 May 28;10(3):e00597-19. doi: 10.1128/mBio.00597-19. mBio. 2019. PMID: 31138743 Free PMC article.
-
Correlates of vaccine-induced protective immunity against Ebola virus disease.Semin Immunol. 2018 Oct;39:65-72. doi: 10.1016/j.smim.2018.07.003. Epub 2018 Jul 21. Semin Immunol. 2018. PMID: 30041831 Review.
-
Remdesivir against COVID-19 and Other Viral Diseases.Clin Microbiol Rev. 2020 Oct 14;34(1):e00162-20. doi: 10.1128/CMR.00162-20. Print 2020 Dec 16. Clin Microbiol Rev. 2020. PMID: 33055231 Free PMC article. Review.
Cited by
-
Disease tolerance as immune defense strategy in bats: One size fits all?PLoS Pathog. 2024 Sep 5;20(9):e1012471. doi: 10.1371/journal.ppat.1012471. eCollection 2024 Sep. PLoS Pathog. 2024. PMID: 39236038 Free PMC article. Review.
-
Immune correlates of protection as a game changer in tuberculosis vaccine development.NPJ Vaccines. 2024 Oct 30;9(1):208. doi: 10.1038/s41541-024-01004-w. NPJ Vaccines. 2024. PMID: 39478007 Free PMC article. Review.
-
Medical implications of gas producing probiotics: anti-inflammation and immunity enhancement for ameliorating disease severity.Med Gas Res. 2024 Sep 1;14(3):140-141. doi: 10.4103/mgr.MEDGASRES-D-23-00041. Epub 2024 Mar 20. Med Gas Res. 2024. PMID: 40232691 Free PMC article. No abstract available.
-
Recent Advances in Immunological Landscape and Immunotherapeutic Agent of Nipah Virus Infection.Cell Biochem Biophys. 2024 Dec;82(4):3053-3069. doi: 10.1007/s12013-024-01424-4. Epub 2024 Jul 25. Cell Biochem Biophys. 2024. PMID: 39052192 Review.
-
Evolutionary, comparative, and functional analyses of STATs and regulation of the JAK-STAT pathway in lumpfish upon bacterial and poly(I:C) exposure.Front Cell Infect Microbiol. 2023 Sep 22;13:1252744. doi: 10.3389/fcimb.2023.1252744. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37808912 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous